{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Type II restriction endonuclease RleAI", "item": "https://www.patentleaderboard.com/patent/5134067"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Type II restriction endonuclease RleAI

Type II restriction endonuclease RleAI

US Patent 5134067 · Granted Jul 28, 1992

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for the prediction of a personalized ESA-dose in the treatment of anemia2020
Anti-alpha-synuclein antibodies and methods of use2020
Antibodies against human CSF-1R and uses thereof2019
Anti-alpha-synuclein antibodies and methods of use2019
Antibodies against human CSF-1R and uses thereof2019
Antibodies against human CSF-1R and uses thereof2018
Antibodies against human CSF-1R and uses thereof2018
Antibodies against human CSF-1R and uses thereof2018
Antibodies against human CSF-1R and uses thereof2018
Antibodies against human CSF-1R and uses thereof2018
Anti-alpha-synuclein antibodies and methods of use2018
Antibodies against human CSF-1R and uses thereof2018